ID   PANK4_HUMAN             Reviewed;         773 AA.
AC   Q9NVE7; B9DI84; Q53EU3; Q5TA84; Q7RTX3; Q9H3X5;
DT   17-JAN-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   28-JUN-2023, entry version 178.
DE   RecName: Full=4'-phosphopantetheine phosphatase {ECO:0000303|PubMed:27322068};
DE            EC=3.1.3.- {ECO:0000269|PubMed:27322068};
DE   AltName: Full=Inactive pantothenic acid kinase 4 {ECO:0000303|PubMed:30927326};
DE            Short=hPanK4;
GN   Name=PANK4 {ECO:0000312|HGNC:HGNC:19366};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-684.
RC   TISSUE=Kidney;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 6-773, AND VARIANT VAL-547.
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   IDENTIFICATION, AND TISSUE SPECIFICITY.
RX   PubMed=11479594; DOI=10.1038/ng572;
RA   Zhou B., Westaway S.K., Levinson B., Johnson M.A., Gitschier J.,
RA   Hayflick S.J.;
RT   "A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-
RT   Spatz syndrome.";
RL   Nat. Genet. 28:345-349(2001).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-393 AND SER-404, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY
RP   REGULATION, AND COFACTOR.
RX   PubMed=27322068; DOI=10.1038/nchembio.2108;
RA   Huang L., Khusnutdinova A., Nocek B., Brown G., Xu X., Cui H., Petit P.,
RA   Flick R., Zallot R., Balmant K., Ziemak M.J., Shanklin J.,
RA   de Crecy-Lagard V., Fiehn O., Gregory J.F. III, Joachimiak A.,
RA   Savchenko A., Yakunin A.F., Hanson A.D.;
RT   "A family of metal-dependent phosphatases implicated in metabolite damage-
RT   control.";
RL   Nat. Chem. Biol. 12:621-627(2016).
RN   [16]
RP   LACK OF PANTOTHENATE KINASE ACTIVITY, AND MUTAGENESIS OF VAL-147 AND
RP   TRP-211.
RX   PubMed=30927326; DOI=10.1002/pro.3611;
RA   Yao J., Subramanian C., Rock C.O., Jackowski S.;
RT   "Human pantothenate kinase 4 is a pseudo-pantothenate kinase.";
RL   Protein Sci. 28:1031-1047(2019).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-475.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [18]
RP   INVOLVEMENT IN CTRCT49, AND TISSUE SPECIFICITY.
RX   PubMed=30585370; DOI=10.1002/humu.23696;
RA   Sun M., Chen C., Hou S., Li X., Wang H., Zhou J., Chen X., Liu P.,
RA   Kijlstra A., Lin S., Ye J.;
RT   "A novel mutation of PANK4 causes autosomal dominant congenital posterior
RT   cataract.";
RL   Hum. Mutat. 40:380-391(2019).
CC   -!- FUNCTION: Phosphatase which shows a preference for 4'-
CC       phosphopantetheine and its oxidatively damaged forms (sulfonate or S-
CC       sulfonate), providing strong indirect evidence that the phosphatase
CC       activity pre-empts damage in the coenzyme A (CoA) pathway
CC       (PubMed:27322068). Hydrolyzing excess 4'-phosphopantetheine could
CC       constitute a directed overflow mechanism to prevent its oxidation to
CC       the S-sulfonate, sulfonate, or other forms (PubMed:27322068).
CC       Hydrolyzing 4'-phosphopantetheine sulfonate or S-sulfonate would
CC       forestall their conversion to inactive forms of CoA and acyl carrier
CC       protein (PubMed:27322068). May play a role in the physiological
CC       regulation of CoA intracellular levels (Probable).
CC       {ECO:0000269|PubMed:27322068, ECO:0000305|PubMed:27322068}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-4'-phosphopantetheine + H2O = (R)-pantetheine + phosphate;
CC         Xref=Rhea:RHEA:68328, ChEBI:CHEBI:15377, ChEBI:CHEBI:16753,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:61723;
CC         Evidence={ECO:0000269|PubMed:27322068};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68329;
CC         Evidence={ECO:0000305|PubMed:27322068};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-4'-phosphopantetheine sulfonate + H2O = (R)-pantetheine
CC         sulfonate + phosphate; Xref=Rhea:RHEA:68336, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:177300, ChEBI:CHEBI:177301;
CC         Evidence={ECO:0000269|PubMed:27322068};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68337;
CC         Evidence={ECO:0000305|PubMed:27322068};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-4'-phospho-S-sulfopantetheine + H2O = (R)-S-
CC         sulfopantetheine + phosphate; Xref=Rhea:RHEA:68340,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:177302,
CC         ChEBI:CHEBI:177303; Evidence={ECO:0000269|PubMed:27322068};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:68341;
CC         Evidence={ECO:0000305|PubMed:27322068};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:27322068};
CC       Name=Ni(2+); Xref=ChEBI:CHEBI:49786;
CC         Evidence={ECO:0000269|PubMed:27322068};
CC       Note=Phosphatase activity is strongly promoted by several divalent
CC       cation ions but it is suggested s that Mn(2+) and possibly Ni(2+)
CC       represent biologically relevant metal ion cofactors for damage-control
CC       phosphatases. {ECO:0000269|PubMed:27322068};
CC   -!- ACTIVITY REGULATION: Activity is strongly promoted by Co(2+), Ni(2+),
CC       Mg(2+) and Mn(2+) (PubMed:27322068). Activity is inhibited by EDTA
CC       (PubMed:27322068). {ECO:0000269|PubMed:27322068}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1920 uM for p-nitrophenylphosphate {ECO:0000269|PubMed:27322068};
CC         KM=150 uM for D-pantetheine 4'-phosphate
CC         {ECO:0000269|PubMed:27322068};
CC         KM=3.9 uM for D-pantetheine 4'-phosphate-sulfonate
CC         {ECO:0000269|PubMed:27322068};
CC         Note=kcat is 0.17 sec(-1) with p-nitrophenylphosphate as substrate.
CC         kcat is 0.71 sec(-1) with D-pantetheine 4'-phosphate as substrate.
CC         kcat is 0.09 sec(-1) with D-pantetheine 4'-phosphate-sulfonate as
CC         substrate. {ECO:0000269|PubMed:27322068};
CC   -!- SUBUNIT: Homodimer. Interacts with PKM. {ECO:0000250|UniProtKB:Q923S8}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q923S8}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with high expression in the muscle
CC       (PubMed:11479594). Expressed in the retina and lens epithelium, mainly
CC       in ganglion cell layer, outer plexiform layer and retinal pigment layer
CC       (at protein level) (PubMed:30585370). {ECO:0000269|PubMed:11479594,
CC       ECO:0000269|PubMed:30585370}.
CC   -!- DOMAIN: Subfamily II proteins have an EGMGR motif about 50 residues
CC       from the C-terminus (Probable). This motif lies near the metal-binding
CC       residues in the putative substrate-binding cleft 2 (Probable).
CC       Subfamily II proteins occur only in eukaryotes, in two forms: as a
CC       stand-alone unit in plants, and as a C-terminal domain of pantothenate
CC       kinases in plants, animals, and chytrid fungi (Probable).
CC       {ECO:0000305|PubMed:27322068}.
CC   -!- DISEASE: Cataract 49 (CTRCT49) [MIM:619593]: A form of cataract, an
CC       opacification of the crystalline lens of the eye that frequently
CC       results in visual impairment or blindness. Opacities vary in
CC       morphology, are often confined to a portion of the lens, and may be
CC       static or progressive. In general, the more posteriorly located and
CC       dense an opacity, the greater the impact on visual function. CTRCT49 is
CC       an autosomal dominant form characterized by congenital cataract located
CC       in the posterior region of the lens. Visual impairment has onset in
CC       early childhood. {ECO:0000269|PubMed:30585370}. Note=The disease may be
CC       caused by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the type II
CC       pantothenate kinase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the damage-control
CC       phosphatase family. Phosphopantetheine phosphatase II subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Despite belonging to the type II pantothenate kinase family,
CC       the pantothenate kinase domain contains a Val residue at position 147
CC       and a Trp residue at position 211 instead of the two conserved active
CC       site residues, Glu and Arg. Lacks pantothenate kinase activity.
CC       {ECO:0000269|PubMed:30927326}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK001644; BAA91805.1; -; mRNA.
DR   EMBL; AK223546; BAD97266.1; -; mRNA.
DR   EMBL; AL139246; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471183; EAW56097.1; -; Genomic_DNA.
DR   EMBL; BC043496; AAH43496.1; -; mRNA.
DR   EMBL; AL442072; CAC09438.1; -; mRNA.
DR   EMBL; BK000012; DAA00006.1; -; Genomic_DNA.
DR   CCDS; CCDS42.3; -.
DR   RefSeq; NP_060686.2; NM_018216.2.
DR   AlphaFoldDB; Q9NVE7; -.
DR   SMR; Q9NVE7; -.
DR   BioGRID; 120524; 75.
DR   IntAct; Q9NVE7; 8.
DR   MINT; Q9NVE7; -.
DR   STRING; 9606.ENSP00000367727; -.
DR   iPTMnet; Q9NVE7; -.
DR   MetOSite; Q9NVE7; -.
DR   PhosphoSitePlus; Q9NVE7; -.
DR   SwissPalm; Q9NVE7; -.
DR   BioMuta; PANK4; -.
DR   DMDM; 27805669; -.
DR   EPD; Q9NVE7; -.
DR   jPOST; Q9NVE7; -.
DR   MassIVE; Q9NVE7; -.
DR   MaxQB; Q9NVE7; -.
DR   PaxDb; Q9NVE7; -.
DR   PeptideAtlas; Q9NVE7; -.
DR   ProteomicsDB; 82788; -.
DR   Antibodypedia; 1627; 147 antibodies from 22 providers.
DR   DNASU; 55229; -.
DR   Ensembl; ENST00000378466.9; ENSP00000367727.5; ENSG00000157881.16.
DR   Ensembl; ENST00000615291.3; ENSP00000478189.1; ENSG00000273494.3.
DR   GeneID; 55229; -.
DR   KEGG; hsa:55229; -.
DR   MANE-Select; ENST00000378466.9; ENSP00000367727.5; NM_018216.4; NP_060686.3.
DR   UCSC; uc001ajm.2; human.
DR   AGR; HGNC:19366; -.
DR   CTD; 55229; -.
DR   DisGeNET; 55229; -.
DR   GeneCards; PANK4; -.
DR   GeneReviews; PANK4; -.
DR   HGNC; HGNC:19366; PANK4.
DR   HPA; ENSG00000157881; Low tissue specificity.
DR   MalaCards; PANK4; -.
DR   MIM; 606162; gene.
DR   MIM; 619593; phenotype.
DR   neXtProt; NX_Q9NVE7; -.
DR   OpenTargets; ENSG00000157881; -.
DR   Orphanet; 98993; Early-onset posterior polar cataract.
DR   PharmGKB; PA134887214; -.
DR   VEuPathDB; HostDB:ENSG00000157881; -.
DR   eggNOG; KOG2201; Eukaryota.
DR   eggNOG; KOG4584; Eukaryota.
DR   GeneTree; ENSGT00940000158896; -.
DR   HOGENOM; CLU_012496_1_1_1; -.
DR   InParanoid; Q9NVE7; -.
DR   OMA; IEHCMKE; -.
DR   OrthoDB; 167164at2759; -.
DR   PhylomeDB; Q9NVE7; -.
DR   TreeFam; TF342917; -.
DR   BioCyc; MetaCyc:HS08249-MON; -.
DR   PathwayCommons; Q9NVE7; -.
DR   Reactome; R-HSA-196783; Coenzyme A biosynthesis.
DR   SignaLink; Q9NVE7; -.
DR   BioGRID-ORCS; 55229; 14 hits in 1155 CRISPR screens.
DR   ChiTaRS; PANK4; human.
DR   GeneWiki; PANK4; -.
DR   GenomeRNAi; 55229; -.
DR   Pharos; Q9NVE7; Tbio.
DR   PRO; PR:Q9NVE7; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9NVE7; protein.
DR   Bgee; ENSG00000157881; Expressed in apex of heart and 92 other tissues.
DR   ExpressionAtlas; Q9NVE7; baseline and differential.
DR   Genevisible; Q9NVE7; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0015937; P:coenzyme A biosynthetic process; IBA:GO_Central.
DR   Gene3D; 3.30.420.40; -; 1.
DR   Gene3D; 3.30.420.510; -; 1.
DR   Gene3D; 1.20.1700.10; AF1104-like; 1.
DR   Gene3D; 3.40.50.10880; Uncharacterised protein PF01937, DUF89, domain 3; 1.
DR   InterPro; IPR036075; ARMT-1-like_metal-bd_sf.
DR   InterPro; IPR002791; ARMT1-like_metal-bd.
DR   InterPro; IPR035073; At2g17340_3_helix_bundle.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR015844; PanK_long.
DR   InterPro; IPR004567; Type_II_PanK.
DR   PANTHER; PTHR12280:SF20; 4'-PHOSPHOPANTETHEINE PHOSPHATASE; 1.
DR   PANTHER; PTHR12280; PANTOTHENATE KINASE; 1.
DR   Pfam; PF01937; ARMT1-like_dom; 1.
DR   Pfam; PF03630; Fumble; 1.
DR   PIRSF; PIRSF036939; PanK_long; 1.
DR   SUPFAM; SSF53067; Actin-like ATPase domain; 2.
DR   SUPFAM; SSF111321; AF1104-like; 1.
DR   TIGRFAMs; TIGR00555; panK_eukar; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cataract; Coenzyme A biosynthesis; Cytoplasm;
KW   Hydrolase; Manganese; Metal-binding; Nickel; Nitration; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   CHAIN           2..773
FT                   /note="4'-phosphopantetheine phosphatase"
FT                   /id="PRO_0000161806"
FT   REGION          2..402
FT                   /note="Pantothenate kinase"
FT                   /evidence="ECO:0000305|PubMed:27322068"
FT   REGION          403..773
FT                   /note="4'-phosphopantetheine phosphatase"
FT                   /evidence="ECO:0000305|PubMed:27322068"
FT   MOTIF           724..728
FT                   /note="Subfamily II EGMGR motif"
FT                   /evidence="ECO:0000305|PubMed:27322068"
FT   BINDING         196
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250"
FT   BINDING         199
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250"
FT   BINDING         623
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_note="catalytic; for phosphatase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q04371"
FT   BINDING         624
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_note="catalytic; for phosphatase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q04371"
FT   BINDING         659
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /ligand_note="catalytic; for phosphatase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q04371"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:19413330"
FT   MOD_RES         320
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80YV4"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         404
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         406
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80YV4"
FT   VARIANT         475
FT                   /note="E -> K (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs966358882)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035470"
FT   VARIANT         547
FT                   /note="A -> V (in dbSNP:rs7535528)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_027409"
FT   VARIANT         684
FT                   /note="Q -> R (in dbSNP:rs2494620)"
FT                   /evidence="ECO:0000269|Ref.2"
FT                   /id="VAR_015170"
FT   MUTAGEN         147
FT                   /note="V->E: Does not induce acetyl-CoA production.
FT                   Restores a moderate increase in acetyl-CoA production; when
FT                   associated with R-211."
FT                   /evidence="ECO:0000269|PubMed:30927326"
FT   MUTAGEN         211
FT                   /note="W->R: Does not induce acetyl-CoA production.
FT                   Restores a moderate increase in acetyl-CoA production; when
FT                   associated with E-147."
FT                   /evidence="ECO:0000269|PubMed:30927326"
SQ   SEQUENCE   773 AA;  85991 MW;  D55027171A85E8B6 CRC64;
     MAECGASGSG SSGDSLDKSI TLPPDEIFRN LENAKRFAID IGGSLTKLAY YSTVQHKVAK
     VRSFDHSGKD TEREHEPPYE ISVQEEITAR LHFIKFENTY IEACLDFIKD HLVNTETKVI
     QATGGGAYKF KDLIEEKLRL KVDKEDVMTC LIKGCNFVLK NIPHEAFVYQ KDSDPEFRFQ
     TNHPHIFPYL LVNIGSGVSI VKVETEDRFE WVGGSSIGGG TFWGLGALLT KTKKFDELLH
     LASRGQHSNV DMLVRDVYGG AHQTLGLSGN LIASSFGKSA TADQEFSKED MAKSLLHMIS
     NDIGQLACLH ARLHSLDRVY FGGFFIRGHP VTMRTITYSI NFFSKGEVQA LFLRHEGYLG
     AIGAFLKGAE QDNPNQYSWG ENYAGSSGLM SASPELGPAQ RARSGTFDLL EMDRLERPLV
     DLPLLLDPPS YVPDTVDLTD DALARKYWLT CFEEALDGVV KRAVASQPDS VDAAERAEKF
     RQKYWNKLQT LRQQPFAYGT LTVRSLLDTR EHCLNEFNFP DPYSKVKQRE NGVALRCFPG
     VVRSLDALGW EERQLALVKG LLAGNVFDWG AKAVSAVLES DPYFGFEEAK RKLQERPWLV
     DSYSEWLQRL KGPPHKCALI FADNSGIDII LGVFPFVREL LLRGTEVILA CNSGPALNDV
     THSESLIVAE RIAGMDPVVH SALQEERLLL VQTGSSSPCL DLSRLDKGLA ALVRERGADL
     VVIEGMGRAV HTNYHAALRC ESLKLAVIKN AWLAERLGGR LFSVIFKYEV PAE
//
